The Doctor Youn Show The Truth About GLP-1 Weight Loss Drugs: Muscle Loss, Microdosing & Long-Term Use with Dr. Spencer Nadolsky
12 snips
Feb 2, 2026 
Dr. Spencer Nadolsky, an obesity medicine specialist and founder of Vineyard Health, joins to demystify GLP-1 weight loss drugs. He explains who benefits from these medications and compares semaglutide versus tirzepatide. He addresses muscle loss concerns, discusses microdosing and off-label uses, and talks about how long people might need treatment. He stresses combining meds with strength training, nutrition, and real coaching.
AI Snips
Chapters
Books
Transcript
Episode notes
Choose Comprehensive Care Over Scripts
- Use an obesity program that pairs physician care with dietitians and coaching rather than prescription-only services.
- Adjust medications, blood pressure, and labs proactively instead of sending patients back to a primary care bottleneck.
Genes Meet A Hyperpalatable Environment
- Obesity arises from genetics interacting with an environment engineered to promote overconsumption.
- Ultra‑palatable, highly processed foods and convenience reshape appetite and increase intake unconsciously.
Self-Reported Diets Are Unreliable
- People routinely misjudge calorie intake and activity by large margins.
- Metabolic ward studies show perceived intake/activity often differs dramatically from reality.
